BioCatalystWatch
BFRIWorkspace / BFRI / OverviewCompany library

Biofrontera Inc.

Biofrontera Inc. (BFRI)

Featured programme · Ameluz®

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Ameluz®

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ameluz®

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Ameluz®

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ameluz®

PreINDP1P2P3FilingApproved

Other pipelines

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

Ameluz®

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ameluz®

Approved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BFRI PR & News

PR & News

BFRI SEC archive